Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen

Geen geregistreerde merken gevonden voor deze werkzame stof.

Geen geregistreerde voedingsnotities voor deze werkzame stof.

• Acetylsalicylic acidMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Acetylsalicylic acid.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Acetylsalicylic acid.

• AloxiprinMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Aloxiprin.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Aloxiprin.

• Aminosalicylic acidMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Aminosalicylic acid.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Aminosalicylic acid.

• BalsalazideMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Balsalazide.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Balsalazide.

• Bismuth subsalicylateMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Bismuth subsalicylate.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Bismuth subsalicylate.

• Carbaspirin calciumMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Carbaspirin calcium.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Carbaspirin calcium.

• Choline salicylateMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Choline salicylate.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Choline salicylate.

• DersalazineMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Dersalazine.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Dersalazine.

• DiflunisalMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Diflunisal.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Diflunisal.

• GuacetisalMATIG

  Het risico of de ernst van syndroom van Reye kan toenemen wanneer Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen wordt gecombineerd met Guacetisal.

  Expertweergave

  The risk or severity of Reye's syndrome can be increased when Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen is combined with Guacetisal.